EUVIMEDEUVIMED entdecken
Crossref

Pharmacological mechanism of salidroside in gastric cancer

Jie-Ling Wu

Integrate Medicine · 30.11.2024

DOI: 10.61958/imhd1743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrate Medicine, online erschienen am 30.11.2024. Verfasst von Jie-Ling Wu. Die Arbeit nennt 67 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to investigate the pharmacological mechanisms of salidroside in treating gastric cancer (GC) using network pharmacology combined with experimental validation.

Methods

Targets associated with "stomach," GC, and salidroside were retrieved by accessing public databases, including GeneCards, the Herb Ingredient Targets database (HERB), the Traditional Chinese Medicine Systems Pharmacology database (TCMSP), and the Encyclopedia of Traditional Chinese Medicine (ETCM), for further bioinformatic analyses. Gene Ontology (GO) analysis, protein-protein interaction (PPI) analysis, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to find the core signal pathway and molecular network.

Results

Venn chart exhibited 65 common targets among stomach-related targets, GC-related targets, and salidroside-associated targets. PPI network revealed the potential key genes, such as protein kinase B (AKT1), B-cell lymphoma 2 (BCL2), and caspase 3 (CASP3). Gene Ontology enrichment analysis identified 1,872 biological processes, 79 cellular components, and 142 molecular functions. Kyoto Encyclopedia of Genes and Genomes pathway analysis suggested that the anti-cancer effects of salidroside are mediated through pathways such as the phosphatidylinositol 3-kinase (PI3K)-AKT1 signaling pathway.

Conclusions

This study highlights the potential clinical significance of salidroside in gastric cancer treatment, as demonstrated through network pharmacology.

Zitieren

APA

Wu, J. (2024). Pharmacological mechanism of salidroside in gastric cancer. Integrate Medicine. https://doi.org/10.61958/imhd1743

Vancouver

Wu J. Pharmacological mechanism of salidroside in gastric cancer. Integrate Medicine. 2024. doi:10.61958/imhd1743

BibTeX
@article{Wu2024,
  author = {Wu, Jie-Ling},
  title = {Pharmacological mechanism of salidroside in gastric cancer},
  journal = {Integrate Medicine},
  year = {2024},
  doi = {10.61958/imhd1743}
}
Kostenlos starten →